Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into a license and collaboration agreement with Innovent Biologics (HKEX: 01801) for the development, manufacturing and commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback